Virios Therapeutics, Inc.
VIRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$13 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.52 | -0.28 | -1.1 | -1.92 |
| % Growth | -4,371.4% | 74.5% | 42.7% | – |
| Operating Cash Flow | -$9 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$9 | -$0 | -$0 | -$0 |